Liberty Biopharma (CVE:LTY) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Liberty Biopharma Inc (CVE:LTY) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.

Liberty Biopharma Stock Up ∞

The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The stock’s 50-day moving average price is C$2.00 and its 200-day moving average price is C$2.00. The company has a market cap of C$21.54 million and a P/E ratio of -12.66.

About Liberty Biopharma

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.